Prascend (pergolide mesylate), dopamine receptor agonist, is the first and only FDA-approved treatment for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses. Each tablet contains 1 mg of pergolide mesylate. For oral use in horses.

Prascend (pergolide mesylate), 1 mg tab

SKU: 364215376135199
PriceFrom $171.50
  • Prescription items are non-returnable

  • $12 rebate on 60 count box!

    $30 rebate on 160 count box!

    Go to www.boehringeringelheimequinerebates.com, submit a copy of the invoice, and get cash back.

    Good for products purchased from a veterinarian between Mar 1, 2021 - Dec 31, 2021. Rebate request must be received on or before Mar 1, 2022.